# Joung_Immunotherapy_Manuscript
Code for Joung et al, manuscript. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Please note that the code is published as is for reference.
